FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component

131244 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
hydrocortisone 1% modified cream, 15 g Unknown Cell Type 2
hydrocortisone 1% modified cream, 30 g Unknown Cell Type 2
hydrocortisone 1% cream hydrocortisone 1% cream
hydrocortisone 1% cream, 15 g hydrocortisone 1% cream, 15 g
hydrocortisone 1% cream, 30 g hydrocortisone 1% cream, 30 g
hydrocortisone 10 mg / 1 g modified cream (medicinal product unit of use) Unknown Cell Type 2
hydrocortisone 10 mg / 1 g modified cream, 15 g (medicinal product pack) Unknown Cell Type 2
hydrocortisone 10 mg / 1 g modified cream, 30 g (medicinal product pack) Unknown Cell Type 2
hydrocortisone 1% spray hydrocortisone 1% spray
hydrocortisone 1% spray, 30 mL hydrocortisone 1% spray, 30 mL
hydrocortisone 0.5% cream hydrocortisone 0.5% cream
hydrocortisone 5 mg / 1 g cream, 30 g (medicinal product pack) hydrocortisone 0.5% cream, 30 g
hydrocortisone 5 mg / 1 g modified cream (medicinal product unit of use) Unknown Cell Type 2
hydrocortisone 5 mg / 1 g modified cream, 15 g (medicinal product pack) Unknown Cell Type 2
hydrocortisone 5 mg / 1 g modified cream, 30 g (medicinal product pack) Unknown Cell Type 2
lignocaine + hydrocortisone acetate lidocaine + hydrocortisone
hyoscine hydrobromide trihydrate hyoscine hydrobromide
hyoscine hydrobromide trihydrate 300 microgram chewable tablet hyoscine hydrobromide 300 microgram chewable tablet
hyoscine hydrobromide trihydrate 300 microgram chewable tablet, 10 hyoscine hydrobromide 300 microgram chewable tablet, 10
hyoscine hydrobromide trihydrate 300 microgram chewable tablet, 2 hyoscine hydrobromide 300 microgram chewable tablet, 2
hyoscine hydrobromide trihydrate 300 microgram tablet hyoscine hydrobromide 300 microgram tablet
hyoscine hydrobromide trihydrate 300 microgram tablet, 10 hyoscine hydrobromide 300 microgram tablet, 10
hyoscine hydrobromide trihydrate 300 microgram tablet, 2 hyoscine hydrobromide 300 microgram tablet, 2
hypromellose 20 mg / 1 mL oral gel (medicinal product unit of use) Unknown Cell Type 2
hypromellose 20 mg / 1 mL oral gel, 100 g (medicinal product pack) Unknown Cell Type 2
hypromellose 20 mg/mL oral gel Unknown Cell Type 2
hypromellose 20 mg/mL oral gel, 100 g Unknown Cell Type 2
industrial methylated spirit 1 g/mL application industrial methylated spirit 1 g/mL solution
industrial methylated spirit 1 g/mL application, 500 mL industrial methylated spirit 1 g/mL solution, 500 mL
somatropin 400 microgram/dose + inert substance injection, 7 dual chamber devices somatropin 400 microgram injection [1 chamber] (&) inert substance diluent [0.25 mL chamber], 7 dual chamber syringes
leuprorelin acetate 45 mg injection: modified release [1] (&) inert substance diluent [1 syringe], 1 pack leuprorelin acetate 45 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack
measles virus (Enders' attenuated Edmonston) live vaccine 1000 TCID50 units + mumps virus (Jeryl Lynn B level) live vaccine 12 500 TCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 TCID50 units injection [1 vial] (&) inert substance diluent [1 syringe], 1 pack measles 1000 TCID50 units + mumps 12 500 TCID50 units + rubella 1000 TCID50 units live vaccine injection [1 vial] (&) inert substance diluent [1 syringe], 1 pack
Japanese encephalitis virus live vaccine injection [1 vial] (&) inert substance diluent [1 vial], 1 pack Japanese encephalitis live vaccine injection [1 vial] (&) inert substance diluent [1 vial], 1 pack
romidepsin 10 mg injection [1 vial] (&) inert substance diluent [1 vial], 1 pack romidepsin 10 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack
measles virus (Schwarz) live attenuated vaccine 1000 CCID50 units + mumps virus (Jeryl Lynn, strain RIT 4385) live attenuated vaccine 25 119 CCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 CCID50 units + Varicella zoster live attenuated vaccine 1995 PFU injection [1 vial] (&) inert substance diluent [0.5 mL ampoule], 1 pack measles 1000 CCID50 units + mumps 25 119 CCID50 units + rubella 1000 CCID50 units + varicella-zoster 1995 PFU live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL ampoule], 1 pack
measles virus (Schwarz) live attenuated vaccine 1000 CCID50 units + mumps virus (Jeryl Lynn, strain RIT 4385) live attenuated vaccine 5000 CCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 CCID50 units injection [1 vial] (&) inert substance diluent [0.5 mL ampoule], 1 pack measles 1000 CCID50 units + mumps 5000 CCID50 units + rubella 1000 CCID50 units live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL ampoule], 1 pack
peginterferon alfa-2b 100 microgram injection [1 cartridge] (&) inert substance diluent [0.5 mL cartridge], 1 pack peginterferon alfa-2b 100 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device
peginterferon alfa-2b 120 microgram injection [1 cartridge] (&) inert substance diluent [0.5 mL cartridge], 1 pack peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device
peginterferon alfa-2b 150 microgram injection [1 cartridge] (&) inert substance diluent [0.5 mL cartridge], 1 pack peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device
peginterferon alfa-2b 50 microgram injection [1 cartridge] (&) inert substance diluent [0.5 mL cartridge], 1 pack peginterferon alfa-2b 50 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device
peginterferon alfa-2b 80 microgram injection [1 cartridge] (&) inert substance diluent [0.5 mL cartridge], 1 pack peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device
Varicella zoster live attenuated vaccine 1995 PFU injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack varicella-zoster live vaccine 1995 PFU injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
Yellow fever live attenuated vaccine 1000 units injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack yellow fever live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
measles virus (Schwarz) live attenuated vaccine 1000 CCID50 units + mumps virus (Jeryl Lynn, strain RIT 4385) live attenuated vaccine 25 119 CCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 CCID50 units + Varicella zoster live attenuated vaccine 1995 PFU injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack measles 1000 CCID50 units + mumps 25 119 CCID50 units + rubella 1000 CCID50 units + varicella-zoster 1995 PFU live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
meningococcal group A conjugate vaccine 5 microgram + meningococcal group C conjugate vaccine 5 microgram + meningococcal group W135 conjugate vaccine 5 microgram + meningococcal group Y (Neisseria meningitidis) conjugate vaccine 5 microgram injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack meningococcal A 5 microgram + meningococcal C 5 microgram + meningococcal W135 5 microgram + meningococcal Y 5 microgram conjugate vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
meningococcal group A polysaccharide vaccine 50 microgram + meningococcal group C polysaccharide vaccine 50 microgram + meningococcal group Y polysaccharide vaccine 50 microgram + meningococcal group W135 polysaccharide vaccine 50 microgram injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack meningococcal quadrivalent polysaccharide vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
meningococcal group C conjugate vaccine 10 microgram injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack meningococcal C conjugate vaccine injection [1 vial] (&) inert substance diluent [0.5 mL syringe], 1 pack
meningococcal group A polysaccharide vaccine 50 microgram + meningococcal group C polysaccharide vaccine 50 microgram + meningococcal group Y polysaccharide vaccine 50 microgram + meningococcal group W135 polysaccharide vaccine 50 microgram injection [1 vial] (&) inert substance diluent [0.5 mL vial], 1 pack meningococcal quadrivalent polysaccharide vaccine injection [1 vial] (&) inert substance diluent [0.5 mL vial], 1 pack
rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 TCID50 units injection [1 vial] (&) inert substance diluent [0.5 mL vial], 1 pack rubella live vaccine injection [1 vial] (&) inert substance diluent [0.5 mL vial], 1 pack
Varicella zoster live attenuated vaccine 19 400 PFU injection [1 vial] (&) inert substance diluent [0.65 mL syringe], 1 pack varicella-zoster live vaccine 19 400 PFU injection [1 vial] (&) inert substance diluent [0.65 mL syringe], 1 pack
Varicella zoster live attenuated vaccine 19 400 PFU injection [1 vial] (&) inert substance diluent [0.65 mL vial], 1 pack varicella-zoster live vaccine 19 400 PFU injection [1 vial] (&) inert substance diluent [0.65 mL vial], 1 pack
Varicella zoster live attenuated vaccine 1350 PFU injection [1 vial] (&) inert substance diluent [0.7 mL syringe], 1 pack varicella-zoster live vaccine 1350 PFU injection [1 vial] (&) inert substance diluent [0.7 mL syringe], 1 pack
Varicella zoster live attenuated vaccine 1350 PFU injection [1 vial] (&) inert substance diluent [0.7 mL vial], 1 pack varicella-zoster live vaccine 1350 PFU injection [1 vial] (&) inert substance diluent [0.7 mL vial], 1 pack
rabies inactivated vaccine 2.5 units injection [1 vial] (&) inert substance diluent [1 mL ampoule], 1 pack rabies vaccine injection [1 vial] (&) inert substance diluent [1 mL ampoule], 1 pack
somatropin 12 mg injection [1 cartridge] (&) inert substance diluent [1 mL cartridge], 1 pack somatropin 12 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device
somatropin 5 mg injection [1 cartridge] (&) inert substance diluent [1 mL cartridge], 1 pack somatropin 5 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber pen device
rabies inactivated vaccine 2.5 units injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack rabies vaccine injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack
leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1.5 mL syringe], 1 pack leuprorelin acetate 22.5 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
leuprorelin acetate 30 mg modified release injection [1 syringe] (&) inert substance diluent [1.5 mL syringe], 1 pack leuprorelin acetate 30 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
leuprorelin acetate 45 mg modified release injection [1 syringe] (&) inert substance diluent [1.5 mL syringe], 1 pack leuprorelin acetate 45 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
inert substance diluent [1 x 1.5 mL syringe] (&) leuprorelin acetate 7.5 mg modified release injection [1 x 7.5 mg syringe], 1 pack (medicinal product pack) leuprorelin acetate 7.5 mg modified release injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber syringe
leuprorelin acetate 22.5 mg injection: modified release [1] (&) inert substance diluent [2 mL syringe], 1 pack leuprorelin acetate 22.5 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
leuprorelin acetate 30 mg injection: modified release [1] (&) inert substance diluent [2 mL syringe], 1 pack leuprorelin acetate 30 mg modified release injection [1 chamber] (&) inert substance diluent [1.5 mL chamber], 1 dual chamber syringe
leuprorelin acetate 7.5 mg injection: modified release [1] (&) inert substance diluent [2 mL syringe], 1 pack leuprorelin acetate 7.5 mg modified release injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber syringe
pasireotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack pasireotide (as embonate) 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
pasireotide 40 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack pasireotide (as embonate) 40 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
pasireotide 60 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack pasireotide (as embonate) 60 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
methylprednisolone 125 mg injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack methylprednisolone 125 mg injection [1 chamber] (&) inert substance diluent [2 mL chamber], 1 dual chamber vial
octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack octreotide 10 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack octreotide 20 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [3 mL syringe], 1 pack octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack
Mycobacterium bovis (Bacillus Calmette and Guerin (BCG)) Connaught strain 660 million CFU injection [81 mg vial] (&) inert substance diluent [3 mL vial], 1 pack Mycobacterium bovis BCG Connaught strain 81 mg injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack
olanzapine 210 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack olanzapine (as pamoate) 210 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack
olanzapine 300 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack olanzapine (as pamoate) 300 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack
olanzapine 405 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack olanzapine (as pamoate) 405 mg modified release injection [1 vial] (&) inert substance diluent [3 mL vial], 1 pack
somatropin 6 mg injection [1 cartridge] (&) inert substance diluent [3.15 mL syringe], 1 pack somatropin 6 mg injection [1 cartridge] (&) inert substance diluent [3.17 mL syringe], 1 pack
moroctocog alfa 1000 units injection [1] (&) inert substance diluent [4 mL syringe], 1 pack moroctocog alfa 1000 units injection [1 chamber] (&) inert substance diluent [4 mL chamber], 1 dual chamber syringe
moroctocog alfa 2000 units injection [1] (&) inert substance diluent [4 mL syringe], 1 pack moroctocog alfa 2000 units injection [1 chamber] (&) inert substance diluent [4 mL chamber], 1 dual chamber syringe
moroctocog alfa 250 units injection [1] (&) inert substance diluent [4 mL syringe], 1 pack moroctocog alfa 250 units injection [1 chamber] (&) inert substance diluent [4 mL chamber], 1 dual chamber syringe
moroctocog alfa 3000 units injection [1] (&) inert substance diluent [4 mL syringe], 1 pack inert substance diluent [4 mL chamber] (&) moroctocog alfa 3000 units injection [1 chamber], 1 dual chamber syringe
moroctocog alfa 500 units injection [1] (&) inert substance diluent [4 mL syringe], 1 pack moroctocog alfa 500 units injection [1 chamber] (&) inert substance diluent [4 mL chamber], 1 dual chamber syringe
paper wasp venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial] (&) inert substance diluent [3 x 1.8 mL vials], 1 pack paper wasp venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial] (&) inert substance diluent [3 x 1.8 mL vials], 1 pack
vespula spp venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial] (&) inert substance diluent [3 x 1.8 mL vials], 1 pack yellow jacket venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial] (&) inert substance diluent [3 x 1.8 mL vials], 1 pack
measles virus (Enders' attenuated Edmonston) live vaccine 1000 TCID50 units + mumps virus (Jeryl Lynn B level) live vaccine 12 500 TCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 TCID50 units injection [10 vials] (&) inert substance diluent [10 syringes], 1 pack measles 1000 TCID50 units + mumps 12 500 TCID50 units + rubella 1000 TCID50 units live vaccine injection [10 vials] (&) inert substance diluent [10 syringes], 1 pack
measles virus (Schwarz) live attenuated vaccine 1000 CCID50 units + mumps virus (Jeryl Lynn, strain RIT 4385) live attenuated vaccine 25 119 CCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 CCID50 units + Varicella zoster live attenuated vaccine 1995 PFU injection [10 vials] (&) inert substance diluent [10 x 0.5 mL ampoules], 1 pack measles 1000 CCID50 units + mumps 25 119 CCID50 units + rubella 1000 CCID50 units + varicella-zoster 1995 PFU live vaccine injection [10 vials] (&) inert substance diluent [10 x 0.5 mL ampoules], 1 pack
measles virus (Schwarz) live attenuated vaccine 1000 CCID50 units + mumps virus (Jeryl Lynn, strain RIT 4385) live attenuated vaccine 5000 CCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 CCID50 units injection [10 vials] (&) inert substance diluent [10 x 0.5 mL ampoules], 1 pack measles 1000 CCID50 units + mumps 5000 CCID50 units + rubella 1000 CCID50 units live vaccine injection [10 vials] (&) inert substance diluent [10 x 0.5 mL ampoules], 1 pack
Varicella zoster live attenuated vaccine 1995 PFU injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack varicella-zoster live vaccine 1995 PFU injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack
Yellow fever live attenuated vaccine 1000 units injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack yellow fever live vaccine injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack
measles virus (Schwarz) live attenuated vaccine 1000 CCID50 units + mumps virus (Jeryl Lynn, strain RIT 4385) live attenuated vaccine 25 119 CCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 CCID50 units + Varicella zoster live attenuated vaccine 1995 PFU injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack measles 1000 CCID50 units + mumps 25 119 CCID50 units + rubella 1000 CCID50 units + varicella-zoster 1995 PFU live vaccine injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack
measles virus (Schwarz) live attenuated vaccine 1000 CCID50 units + mumps virus (Jeryl Lynn, strain RIT 4385) live attenuated vaccine 5000 CCID50 units + rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 CCID50 units injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack measles 1000 CCID50 units + mumps 5000 CCID50 units + rubella 1000 CCID50 units live vaccine injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack
meningococcal group C conjugate vaccine 10 microgram injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack meningococcal C conjugate vaccine injection [10 vials] (&) inert substance diluent [10 x 0.5 mL syringes], 1 pack
rubella virus (Wistar RA 27/3) live attenuated vaccine 1000 TCID50 units injection [10 vials] (&) inert substance diluent [10 x 0.5 mL vials], 1 pack rubella live vaccine injection [10 vials] (&) inert substance diluent [10 x 0.5 mL vials], 1 pack
Varicella zoster live attenuated vaccine 19 400 PFU injection [10 vials] (&) inert substance diluent [10 x 0.65 mL syringes], 1 pack varicella-zoster live vaccine 19 400 PFU injection [10 vials] (&) inert substance diluent [10 x 0.65 mL syringes], 1 pack
Varicella zoster live attenuated vaccine 19 400 PFU injection [10 vials] (&) inert substance diluent [10 x 0.65 mL vials], 1 pack varicella-zoster live vaccine 19 400 PFU injection [10 vials] (&) inert substance diluent [10 x 0.65 mL vials], 1 pack
Varicella zoster live attenuated vaccine 1350 PFU injection [10 vials] (&) inert substance diluent [10 x 0.7 mL syringes], 1 pack varicella-zoster live vaccine 1350 PFU injection [10 vials] (&) inert substance diluent [10 x 0.7 mL syringes], 1 pack
Varicella zoster live attenuated vaccine 1350 PFU injection [10 vials] (&) inert substance diluent [10 x 0.7 mL vials], 1 pack varicella-zoster live vaccine 1350 PFU injection [10 vials] (&) inert substance diluent [10 x 0.7 mL vials], 1 pack
Japanese encephalitis inactivated vaccine injection [3 vials] (&) inert substance diluent [3 x 1 mL vials], 1 pack Japanese encephalitis (mouse brain-derived) inactivated vaccine injection [3 vials] (&) inert substance diluent [3 x 1 mL vials], 1 pack
peginterferon alfa-2b 100 microgram injection [4 x 100 microgram cartridges] (&) ribavirin 200 mg capsule [112 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack peginterferon alfa-2b 100 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [112], 1 pack
peginterferon alfa-2b 100 microgram injection [4 cartridges] (&) ribavirin 200 mg capsule [84] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack peginterferon alfa-2b 100 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack
peginterferon alfa-2b 100 microgram injection [4 x 100 microgram cartridges] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack peginterferon alfa-2b 100 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices
peginterferon alfa-2b 120 microgram injection [4 x 120 microgram cartridges] (&) ribavirin 200 mg capsule [140 capsules] (&) inert substance diluent [4 x 0.5 mL cartridges], 1 pack peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [140], 1 pack

Start Previous Page 1295 of 1313 Next End

Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start